Clinical trial
Evaluating Biomarkers of Temporal Interference for Temporal Lobe Epilepsy Under SEEG
NCT07082101 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Biomarkers of Temporal Interference for Temporal Lobe Epilepsy Under SEEG
- Lead sponsor
- Xijing Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 15, 2025
- Completion date
- August 31, 2026
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.